Clinical Trial Update: Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the Bladder [NA]

View source ↗

Summary

Clinical trial update reporting completion of a study evaluating neoadjuvant dasatinib followed by radical cystectomy for urothelial carcinoma of the bladder. R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma of the Bladder

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

Sponsor: Hoosier Cancer Research Network | Conditions: Transitional Cell Carcinoma of the Bladder | NA | Status: COMPLETED | Results posted: 2016-01-15